Europe Viral-Vectored Vaccines Market Report 2016

September 2016 | 128 pages | ID: E482A774F82EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Viral-Vectored Vaccines

Revenue, means the sales value of Viral-Vectored Vaccines

This report studies sales (consumption) of Viral-Vectored Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Bayer HealthCare AG (Germany)
• Biogenesis-Bago (Argentina)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Sante Animale (France)
• Heska Corporation (US)
• Indian Immunologicals Ltd (India)
• Lohmann Animal Health (US)
• Merck Animal Health (US)
• Merial Ltd. (US)
• Protein Sciences Corporation (US)
• Virbac SA (France)
• Zoetis Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Viral-Vectored Vaccines in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Viral-Vectored Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Viral-Vectored Vaccines Market Report 2016

1 VIRAL-VECTORED VACCINES OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Viral-Vectored Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Viral-Vectored Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Viral-Vectored Vaccines (2011-2021)
  1.5.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE VIRAL-VECTORED VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Viral-Vectored Vaccines Market Competition by Manufacturers
  2.1.1 Europe Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Viral-Vectored Vaccines (Volume and Value) by Type
  2.2.1 Europe Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Viral-Vectored Vaccines (Volume and Value) by Countries
  2.3.1 Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Viral-Vectored Vaccines (Volume) by Application

3 GERMANY VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Viral-Vectored Vaccines Sales and Value (2011-2016)
  3.1.1 Germany Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Viral-Vectored Vaccines Sales Price Trend (2011-2016)
3.2 Germany Viral-Vectored Vaccines Sales and Market Share by Manufacturers
3.3 Germany Viral-Vectored Vaccines Sales and Market Share by Type
3.4 Germany Viral-Vectored Vaccines Sales and Market Share by Application

4 FRANCE VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France Viral-Vectored Vaccines Sales and Value (2011-2016)
  4.1.1 France Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  4.1.4 France Viral-Vectored Vaccines Sales Price Trend (2011-2016)
4.2 France Viral-Vectored Vaccines Sales and Market Share by Manufacturers
4.3 France Viral-Vectored Vaccines Sales and Market Share by Type
4.4 France Viral-Vectored Vaccines Sales and Market Share by Application

5 UK VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Viral-Vectored Vaccines Sales and Value (2011-2016)
  5.1.1 UK Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  5.1.5 UK Viral-Vectored Vaccines Sales Price Trend (2011-2016)
5.2 UK Viral-Vectored Vaccines Sales and Market Share by Manufacturers
5.3 UK Viral-Vectored Vaccines Sales and Market Share by Type
5.4 UK Viral-Vectored Vaccines Sales and Market Share by Application

6 RUSSIA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Viral-Vectored Vaccines Sales and Value (2011-2016)
  6.1.1 Russia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
6.2 Russia Viral-Vectored Vaccines Sales and Market Share by Manufacturers
6.3 Russia Viral-Vectored Vaccines Sales and Market Share by Type
6.4 Russia Viral-Vectored Vaccines Sales and Market Share by Application

7 ITALY VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Viral-Vectored Vaccines Sales and Value (2011-2016)
  7.1.1 Italy Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Viral-Vectored Vaccines Sales Price Trend (2011-2016)
7.2 Italy Viral-Vectored Vaccines Sales and Market Share by Manufacturers
7.3 Italy Viral-Vectored Vaccines Sales and Market Share by Type
7.4 Italy Viral-Vectored Vaccines Sales and Market Share by Application

8 SPAIN VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Viral-Vectored Vaccines Sales and Value (2011-2016)
  8.1.1 Spain Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Viral-Vectored Vaccines Sales Price Trend (2011-2016)
8.2 Spain Viral-Vectored Vaccines Sales and Market Share by Manufacturers
8.3 Spain Viral-Vectored Vaccines Sales and Market Share by Type
8.4 Spain Viral-Vectored Vaccines Sales and Market Share by Application

9 BENELUX VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Viral-Vectored Vaccines Sales and Value (2011-2016)
  9.1.1 Benelux Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Viral-Vectored Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Viral-Vectored Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Viral-Vectored Vaccines Sales and Market Share by Type
9.4 Benelux Viral-Vectored Vaccines Sales and Market Share by Application

10 EUROPE VIRAL-VECTORED VACCINES MANUFACTURERS ANALYSIS

10.1 Bayer HealthCare AG (Germany)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Biogenesis-Bago (Argentina)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim GmbH (Germany)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Ceva Sante Animale (France)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Heska Corporation (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Indian Immunologicals Ltd (India)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Lohmann Animal Health (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Merck Animal Health (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Merial Ltd. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Protein Sciences Corporation (US)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Viral-Vectored Vaccines Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Virbac SA (France)
10.12 Zoetis Inc. (US)

11 VIRAL-VECTORED VACCINES MANUFACTURING COST ANALYSIS

11.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Viral-Vectored Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE VIRAL-VECTORED VACCINES MARKET FORECAST (2016-2021)

14.1 Germany Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.2 France Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.3 UK Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.4 Russia Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.5 Italy Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.6 Spain Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.7 Benelux Viral-Vectored Vaccines Sales Forecast (2016-2021)
14.8 Europe Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Viral-Vectored Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table Europe Viral-Vectored Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table Europe Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Europe Viral-Vectored Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Europe Viral-Vectored Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Countries (2011-2016)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Viral-Vectored Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Application (2011-2016)
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Germany Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure France Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure France Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table France Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table UK Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Russia Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Italy Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Spain Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Benelux Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Table Viral-Vectored Vaccines Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)